SLB announced that all applicable waiting periods under the U.S. Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976 have expired. This development legally permits SLB to close its planned acquisition of ChampionX Corporation in the United States.
The expiration of the HSR waiting period removes a significant regulatory hurdle for the $8 billion transaction. This brings the merger closer to its anticipated completion.
This clearance is a crucial step in SLB's strategic move to strengthen its leadership in the production and recovery market. The acquisition aims to enhance SLB's portfolio with ChampionX's expertise in production chemicals and artificial lift.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.